Skip to main content
Kane Biotech
Biofilms
Overview
Understanding Biofilms
coactiv+™
DispersinB
®
Glossary Of Terms
Commercialization Vehicles
Overview
Kane Wound Care & Surgical
Kane Dermatology
About
Overview
Our Team
Careers
Contact
Publications
Blog
Publications / Posters
News / Events
Investors
Overview
News / Events
Company Information
Financial Results
Stock Data
SEDAR
Corporate Governance
Press Releases
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Investors
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Info
Profile
Presentations
Management Team
Contacts
Financial Results
Stock Data
TSX-V:KNE
OTCQB:KNBIF
SEDAR
Governance
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
News / Events
Press Releases
IR Calendar
Email Alerts
All News
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Kane Biotech Announces Second Closing of Private Placement Offering
Dec 17, 2014
Kane Biotech Announces Closing of Private Placement Offering
Dec 9, 2014
Kane Biotech Announces Grant of Options
Nov 19, 2014
Kane Biotech Announces Amendment to Private Placement Offering
Nov 10, 2014
Kane Biotech Appoints Mark Nawacki to the Board of Directors
Oct 8, 2014
Kane Biotech Announces Private Placement Offering
Oct 6, 2014
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest
Sep 24, 2014
Kane Biotech Provides Business and Patent Update
Sep 23, 2014
Kane Biotech Market Activity
Sep 11, 2014
Health Canada Approves DispersinB(R) for Human Use
Jul 22, 2014
1...
23
24
25
26
27
28
29
30
31
32
...40
